A naturally occurring, warm-reactive macroglobulin specific for papain-treated human platelets: preliminary...

Area of Science:

• Immunology
• Hematology
• Biochemistry

Background:

• Naturally occurring antibodies can mediate complement-dependent cytotoxicity.
• Platelet surface glycoproteins are targets for various immune mechanisms.

Purpose of the Study:

• To identify and characterize a novel immunoglobulin with platelet-lytic activity.
• To investigate the specificity and properties of this naturally occurring factor.

Main Methods:

• Sera from normal individuals were tested for complement-dependent platelet lysis.
• Platelet reactivity was assessed after treatment with various enzymes.
• Immunoglobulin characterization was performed, including temperature dependence and binding studies.
• Platelets from patients with Glanzmann's thrombasthenia were used to assess target specificity.

Main Results:

• An immunoglobulin causing complement-dependent lysis of proteolytically treated platelets was found in 25% of subjects.
• The factor reacted with determinants induced by papain or bromelain, but not other enzymes.
• Specificity was confirmed as the factor did not bind to enzyme-treated red blood cells.
• The target determinant could not be induced on platelets from patients with Glanzmann's thrombasthenia.
• The factor exhibited properties of an IgM immunoglobulin in 11 of 20 individuals studied.
• Isolation proved challenging due to the factor's instability.

Conclusions:

• A novel, naturally occurring immunoglobulin capable of inducing complement-dependent platelet lysis upon minimal proteolysis has been identified.
• This factor targets specific platelet surface determinants, distinct from those in Glanzmann's thrombasthenia.
• While not currently linked to disease, its potential to cause platelet destruction warrants further investigation.